Tag: COVID-19

Succession planning post-COVID: Identifying the right people

When Donna Doyle, DNP, RN, CNOR, NE-BC, perioperative consultant with DJD Consulting Services in Columbus, Ohio, thinks of succession planning, the British royal family comes to mind. “That is the epitome of succession planning,” she says. “You know exactly who’s in what position, who is next up, and who is…

Read More

By: Jennifer Lubell
June 28, 2022
Share

Contrast media shortage reveals cracks in supply chain

May 2022 saw a critical shortage of the iodinated contrast medium (ICM) iohexol that extended well into June because of a COVID-19-related shutdown of a GE Healthcare plant in Shanghai, China, that interrupted the manufacture of ICM. According to the American College of Radiology, contrast media were added to the…

Read More

By: Tarsilla Moura
June 28, 2022
Share

Hospitals can still be better prepared for natural disasters

When a natural disaster strikes—whether flood, tornado, hurricane, or wildfire—nearly every aspect of a healthcare system’s operations are impacted. There is an influx of patients in crisis and a spike in calls for emergency services. There are logistical problems—impassable roads, power outages, and communication and internet breakdowns. Supply chain disruptions…

Read More

By: Brita Belli
June 28, 2022
Share

CDC: US COVID-19 cases, deaths declining

Editor's Note According to the June 24 Becker’s Hospital Review, the Centers for Disease Control and Prevention’s (CDC’s) latest US COVID-19 statistics include the following: As of June 23, the 7-day average for newly reported COVID-19 cases dropped 5.6% to 97,430. The weekly average for COVID-19 related deaths dropped by…

Read More

By: Judy Mathias
June 27, 2022
Share

Newer COVID-19 subvariants show substantial escape from vaccination, previous infection immunity

Editor's Note In a letter published in the New England Journal of Medicine, researchers at Beth Israel Deaconess Medical Center, Boston, report that the three Omicron subvariants (BA.2.12.1, BA.4, and BA.5) currently dominant in the US substantially escape neutralizing antibodies induced by both vaccination and previous COVID-19 infection. The researchers…

Read More

By: Judy Mathias
June 23, 2022
Share

Machine learning model uses data from wearable devices to detect COVID-19 in HCWs

Editor's Note Researchers at the Icahn School of Medicine, Mount Sinai, New York City, have developed a machine learning model that uses physiological metrics collected from wearable devices that can detect and predict COVID-19 in healthcare workers (HCWs). A total of 407 HCWs from 7 hospitals were enrolled in the…

Read More

By: Judy Mathias
June 23, 2022
Share

FDA monitoring pulse oximeter accuracy and limitations

Editor's Note The US Food and Drug Administration (FDA) released a safety communication update on June 21 alerting providers that the agency “continues to evaluate all available information pertaining to factors that may affect pulse oximeter accuracy and performance.” A May 2022 study published by JAMA Internal Medicine showed that…

Read More

By: Tarsilla Moura
June 23, 2022
Share

FDA, CDC recommend COVID-19 vaccines for children under 5 years old

Editor's Note The Food and Drug Administration (FDA) authorized COVID-19 vaccines for children as young as 6 months old, which expands eligibility to some 20 million babies, toddlers, and preschoolers, CBS News June 17 reports. After convening on Saturday, June 18, the Centers for Disease Control and Prevention (CDC) also…

Read More

By: Tarsilla Moura
June 17, 2022
Share

New Moderna booster candidate announced, Omicron deemed ‘immune evader’

Editor's Note Moderna, Inc announced new clinical data on its “Omicron-containing bivalent” COVID-19 booster candidate and a vaccine candidate targeting the Omicron variant of concern, Healthcare Purchasing News (HPN) June 9 reports. The booster dose of the new mRNA vaccine reportedly had a “superior neutralizing antibody response…against the Omicron variant…

Read More

By: Tarsilla Moura
June 16, 2022
Share

Human broadly neutralizing antibodies could provide immunity against COVID-19 variants

Editor's Note In this French study, two human broadly neutralizing antibodies show promise in providing long-acting immunity against COVID-19 in immunocompromised patients. The antibodies were effective against all COVID-19 variants tested and could be used alone or in an antibody cocktail. Researchers examined 102 spike monoclonal antibodies cloned from IgA…

Read More

By: Judy Mathias
June 16, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat